Table 3.
Characteristics of the Treated Patients Along With Treatment Groups.
| Parameters No. (%) or Median (IQR) |
Overall patients (n = 110) | RFAa (n = 72) | Surgical resectionb (n = 38) | P-Valueavs.b |
|---|---|---|---|---|
| Age, years | 60 (53–65) | 60 (52–65) | 60 (55.5–65) | NS |
| Gender, male | 100 (91%) | 62 (86.1%) | 36 (94.7%) | NS |
| Diabetes | 31 (28.2%) | 24 (33.3%) | 7 (21.8%) | 0.043 |
| Underlying liver disease | 0.032 | |||
| Hepatitis B | 32 (29.1%) | 15 (20.8%) | 18 (47.4%) | |
| Hepatitis C | 42 (38.2%) | 34 (47.2%) | 8 (21%) | |
| ALD | 17 (15.5%) | 12 (16.7%) | 5 (13.1%) | |
| NASH | 19 (17.3%) | 11 (15.3%) | 7 (18.4%) | |
| Smokers | 13 (11.8%) | 8 (11.1%) | 5 (13.2%) | NS |
| Bilirubin (total), mg/Dl | 1.05 (0.7–1.4) | 1.1 (0.8–1.4) | 0.8 (0.6–1.3) | NS |
| AST, IU/L | 60.5 (45–89) | 61.5 (45.7–89) | 55.8 (42.7–89.5) | NS |
| ALT, IU/L | 55.5 (37–78.7) | 55 (35.7–76.2) | 55.5 (39–84.7) | NS |
| Serum albumin, g/dL | 3.5 (3.18–4) | 3.4 (3.1–3.9) | 3.8 (3.4–4.1) | <001 |
| Platelet, nx103/mm3 | 129.5 (95.2–185) | 108 (88.5–147) | 187 (145–239) | <0.01 |
| AFP, ng/ml | 20.4 (7.3–147.7) | 11.5 (6.8–48.2) | 90 (10–307.7) | <0.01 |
| Cirrhosis liver | 94 (85.4%) | 71 (98.6%) | 23 (60.5%) | <0.01 |
| CTP A | 70 (74.5%) | 48 (67.6%) | 22 (95.6%) | 0.019 |
| Tumor size (cm) | 2.85 (2–4.9) | 2.2 (1.9–2.8) | 7.1 (4.8–9.7) | <0.01 |
AFP, alpha fetoprotein; CTP, Child-Turcotte-Pugh; ALD, alcohol-associated liver disease; NASH, non-alcoholic steatohepatitis.